MeSH definition : A family of intracellular tyrosine kinases that participate in the signaling cascade
of cytokines by associating with specific CYTOKINE RECEPTORS. They act upon STAT TRANSCRIPTION
FACTORS in signaling pathway referred to as the JAK/STAT pathway. The name Janus kinase
refers to the fact the proteins have two phosphate-transferring domains.;
A family of intracellular tyrosine kinases that participate in the signaling cascade
of cytokines by associating with specific CYTOKINE RECEPTORS. They act upon STAT TRANSCRIPTION
FACTORS in signaling pathway referred to as the JAK/STAT pathway. The name Janus kinase
refers to the fact the proteins have two phosphate-transferring domains.
https://www.inesss.qc.ca/fileadmin/doc/INESSS/COVID-19/COVID-19_JAKi.pdf 2021 Canada COVID-19 guidelines for drug use janus kinases Janus Kinase Inhibitors pneumonia, viral coronavirus infections pandemics
--- http://www.cri-net.com/ckfinder/userfiles/files/fiches-pratiques/JAKi-juillet2018/JAK_17_Connectivites.pdf 2018 France guideline Janus Kinase Inhibitors janus kinases collagen disease, nos collagen diseases
--- http://www.e-cancer.fr/Expertises-et-publications/Catalogue-des-publications/Medicaments-ciblant-BCR-ABL-Imatinib-Dasatinib-Nilotinib-Bosutinib-Ponatinib-Medicament-ciblant-JAK-Ruxolitinib-Anticancereux-par-voie-orale-informer-prevenir-et-gerer-leurs-effets-indesirables 2016 false false false France French practice guideline antineoplastic agents administration, oral Drug-Related side effects and adverse reactions Drug-Related side effects and adverse reactions information dissemination patient education as topic drug interactions Dasatinib Imatinib Mesylate fusion proteins, bcr-abl protein kinase inhibitors dasatinib imatinib nilotinib nilotinib bosutinib ponatinib ruxolitinib janus kinases ponatinib ruxolitinib bosutinib continuity of patient care pregnancy Tyrosine Kinase Inhibitors nilotinib ruxolitinib aniline compounds nitriles quinolines imidazoles pyridazines pyrimidines pyrazoles
--- http://www.e-cancer.fr/content/download/126025/1524695/file/Médicaments%20ciblant%20BCR-ABL.pdf 2015 false false false France French practice guideline guidelines for drug use administration, oral antineoplastic agents Drug-Related side effects and adverse reactions imatinib dasatinib nilotinib nilotinib bosutinib bosutinib ponatinib ponatinib protein kinase inhibitors ruxolitinib ruxolitinib janus kinases information dissemination continuity of patient care hospital-physician relations hospital-patient relations physician-patient relations drug interactions pregnancy protein-tyrosine kinases Tyrosine Kinase Inhibitor Dasatinib Imatinib Mesylate Tyrosine Kinase Inhibitors nilotinib ruxolitinib pyrazoles aniline compounds nitriles quinolines imidazoles pyridazines